Adam Zayac
Overview
Explore the profile of Adam Zayac including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
David K, Sundaram S, Kim S, Vaca R, Lin Y, Singer S, et al.
Am J Hematol
. 2023 Mar;
98(6):900-912.
PMID: 36965007
There is a paucity of large-scale data delineating outcomes and prognostication of older patients with primary central nervous system lymphoma (PCNSL). We retrospectively analyzed 539 newly-diagnosed PCNSL patients ages ≥60 ...
2.
Agrawal P, David K, Chen Z, Sundaram S, Kim S, Vaca R, et al.
Leuk Lymphoma
. 2023 Mar;
64(5):1026-1034.
PMID: 36960939
The objective of this multicenter retrospective study was to examine the incidence, patient characteristics, pathology, and outcomes associated with Epstein-Barr virus (EBV)-related CNS lymphoma (CNSL) in older patients. Among 309...
3.
Olszewski A, Chorzalska A, Petersen M, Ollila T, Zayac A, Kurt H, et al.
Blood Adv
. 2021 Sep;
5(24):5525-5535.
PMID: 34551072
The diagnosis of parenchymal central nervous system (CNS) invasion and prediction of risk for future CNS recurrence are major challenges in the management of aggressive lymphomas, and accurate biomarkers are...
4.
Ollila T, Lu S, Masel R, Zayac A, Paiva K, Rogers R, et al.
JAMA Oncol
. 2021 Aug;
7(11):1714-1716.
PMID: 34379085
No abstract available.
5.
Alderuccio J, Olszewski A, Evens A, Collins G, Danilov A, Bower M, et al.
Blood Adv
. 2021 Jul;
5(14):2852-2862.
PMID: 34283175
Data addressing prognostication in patients with HIV related Burkitt lymphoma (HIV-BL) currently treated remain scarce. We present an international analysis of 249 (United States: 140; United Kingdom: 109) patients with...
6.
Evens A, Danilov A, Jagadeesh D, Sperling A, Kim S, Vaca R, et al.
Blood
. 2020 Jul;
137(3):374-386.
PMID: 32663292
We examined adults with untreated Burkitt lymphoma (BL) from 2009 to 2018 across 30 US cancer centers. Factors associated with progression-free survival (PFS) and overall survival (OS) were evaluated in...
7.
Zayac A, Almhanna K
Transl Gastroenterol Hepatol
. 2020 Mar;
5:9.
PMID: 32190777
The treatment of advanced, solid-tumor oncology has been reshaped over the last eight years with the development and FDA approval of several immune checkpoint inhibitors (ICIs) comprised of monoclonal antibodies...
8.
Zayac A, Almhanna K
Transl Gastroenterol Hepatol
. 2020 Mar;
5:8.
PMID: 32190776
Primary liver cancers are a heterogenous collection of diseases with variable natural histories and treatments. This review article will focus on hepatocellular carcinoma (HCC), intrahepatic and extrahepatic cholangiocarcinoma, and gallbladder...
9.
Akhtar K, Zayac A, Lemke S
Am J Ther
. 2018 May;
25(6):e763-e765.
PMID: 29746290
No abstract available.
10.
Anand A, Zayac A, Curtiss C, Graziano S
J Thorac Oncol
. 2018 Apr;
13(5):e75-e76.
PMID: 29703540
No abstract available.